Vendor, East Windsor, NJ
Auro Vaccines LLC
UEI JCL5JKNMYAU5, CAGE 8EWB4
1 award and -$22,080 obligated between September 8, 2026 and September 8, 2026, 100% under full and open competition, against 5.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$22,080 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93020C00040Definitive Contract, September 8, 2026, Full and Open Competition, 5 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541714, PSC AN12 | -$22,080 |
- Places of performance
- Maryland
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards